Aroa Biosurgery Ltd (ARX) — Capital Reinvestment Ratio
Latest as of September 2025:
0.12x
Aroa Biosurgery Ltd (ARX) has a Capital Reinvestment Ratio of 0.12x as of September 2025, meaning it reinvests 0% of its operating cash flow (AU$3.64 Million) in capital expenditures (AU$455.08K). See Aroa Biosurgery Ltd free cash flow efficiency to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
0.12x
Capex / Operating Cash Flow
Operating Cash Flow
AU$3.64 Million
AUD
Capital Expenditures
AU$455.08K
AUD
Data as of
Sep 2025
Most recent filing
Aroa Biosurgery Ltd Capital Reinvestment Ratio (2020–2020)
This chart tracks Aroa Biosurgery Ltd's Capital Reinvestment Ratio across 1 annual periods.
Annual Capital Reinvestment Ratio for Aroa Biosurgery Ltd (2020–2020)
Year-by-year Capital Reinvestment Ratio for Aroa Biosurgery Ltd from 2020 to 2020. For live market cap and broader valuation context, see ARX market cap overview.
| Year | Reinvestment Ratio | Operating CF (AUD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2020 | 1.13x | AU$1.58 Million | AU$1.78 Million | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow